Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide Regulatory Status As of June 2026, tirzepatide is FDA-approved under two brand names
Tirzepatide is a class of weight loss drugs that use both GLP-1 and GIP analoguesto achieve sustainable, healthy fat loss
Compounded sublingual drops: typically $149 to $300 per month through telehealth providers
In de meest geciteerde fase 2-studie (NEJM, Jastreboff 2023) verloren deelnemers bij de hoogste dosis gemiddeld 24,2% van hun startgewicht na 48 weken
US$ 24.73
US$ 21.67
US$ 27.05
US$ 24.80
US$ 21.49
US$ 28.33
US$ 24.40
US$ 28.95
US$ 22.50
US$ 26.36
